CIDRAP newsletters options
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Use of a rapid molecular identification test on positive blood cultures from critically ill patients with bloodstream infections was associated with significantly reduced time to optimal antibiotic treatment, Belgian researchers reported yesterday in PLOS One.
The Global Polio Eradication Initiative (GPEI) in its latest weekly update today noted new cases of polio in Pakistan, Angola, and Myanmar—all countries battling ongoing outbreaks of wild or vaccine-derived poliovirus.
Hospitals will be required to have the programs to receive payments from CMS.
The Asian Zika virus strain was found to be the cause, a first for an African country.
The steady trickle of new Ebola cases in the Democratic Republic of the Congo (DRC) continued today, with the World Health Organization (WHO) dashboard showing three new cases and three new fatalities.
The outbreak total now stands at 3,178 cases, with 2,122 deaths, and 520 suspected cases under investigation.
An international group of researchers, in a phase 3 trial, have demonstrated that ceftolozane-tazobactam—an antibiotic approved in 2014 for complicated urinary tract and intra-abdominal infections—is non-inferior to meropenem for serious cases of nosocomial (hospital-acquired) pneumonia, paving the way for a potential new tool for the disease.
Updated recommendations still advise against screening for ASB in nonpregnant women and healthy men.
In addition to being the only US-approved vaccine for preventing monkeypox, Jynneos is also the first FDA-approved non-replicating smallpox vaccine.
With 4 new infections today, the outbreak has reached 3,175 cases.
Health officials in New York's Rockland County today declared the end of a 2018-2019 measles outbreak that sickened 312 people, a development that decreases the chance of the United States losing its measles elimination status on Oct 2.
The FDA proposes a 2-year implementation period after it finalizes the guidance.
Also, Tanzania summons a WHO representative to reaffirm that it is not withholding info on possible cases.
The US Centers for Disease Control and Prevention (CDC) announced yesterday that the Pan American Health Organization (PAHO)/World Health Organization (WHO) have designated the CDC's Center for Global Health as a PAHO/WHO Collaborating Center for Biosafety and Biosecurity.
Immune response and protection were higher when the first dose was given after 9 months of age.
The WHO said it needs clinical data, investigation findings, and information on contacts and lab tests to fully assess the risk.
Officials from the US Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) said today during the United Nations General Assembly (UNGA) in New York that they've received nearly 350 commitments from corporations, non-profit organizations, and health officials in 33 countries to take specific actions against antimicrobial resistance (AMR).
The Centers for Disease Control and Prevention (CDC) late last week released a summary of foodborne illnesses in 2017 based on an annual analysis of data from the Foodborne Disease Outbreak Surveillance System, and norovirus was the most common pathogen reported, responsible for 46% of illnesses. Salmonella and Shiga toxin–producing Escherichia coli were also linked to a substantial number of outbreaks.
"India and China are by far the biggest hot spots of antimicrobial resistance in animals."
"Ebola is a reality, not a chimera," Gressly says, urging cooperation with response efforts.
